Core Insights - Urbanfund Corp. has filed its financial statements for the three and nine months ended September 30, 2025, along with the corresponding Management's Discussion and Analysis [1] Business Overview and Strategy - Urbanfund Corp. is listed on the TSX Venture Exchange under the symbol UFC and focuses on investing in Canadian real estate, including both residential and commercial properties [2] - The company's assets are located in various cities across Ontario, Quebec, and Nova Scotia [2] Operational Highlights - Urbanfund's strength lies in its ability to attract partners with proven expertise in residential and commercial development [3] Results from Operations - For the three months ended September 30, 2025, rental revenue was CAD 2,154,357, an increase from CAD 2,090,060 in the same period of 2024 [7] - Income before taxes for the same period was CAD 2,614,412, compared to CAD 2,101,886 in 2024 [7] - Net income attributable to shareholders for the three months ended September 30, 2025, was CAD 2,223,823, up from CAD 1,516,042 in 2024 [10] Selected Quarterly Information - During the nine months ended September 30, 2025, Urbanfund sold four commercial units at 1040 Martin Grove Road for total sales proceeds of CAD 1,685,124, compared to five units for CAD 2,243,194 in 2024 [6] - At 270-330 Esna Park Drive, 18 commercial units were sold for CAD 3,354,897, a significant increase from three units for CAD 677,706 in 2024 [6] Financial Position - As of September 30, 2025, total assets were CAD 156,323,215, compared to CAD 155,604,351 at the end of 2024 [7] - Total investment properties amounted to CAD 109,476,000, up from CAD 108,843,000 in 2024 [7] - Total mortgages payable were CAD 54,337,105, slightly down from CAD 55,506,091 in 2024 [7] Liquidity and Capital Resources - Urbanfund's liquidity as of September 30, 2025, was CAD 10,412,857, representing 19.1% of its total debt of CAD 54,393,462 [14] - The company expects to meet all obligations, including dividends to shareholders and capital expenditures, through cash flows generated from operating activities [13] Dividend Reinvestment Plan - Urbanfund has a Dividend Reinvestment Plan (DRIP) that allows shareholders to reinvest dividends to acquire additional shares at a discount [16] - The annual dividend rate was increased to CAD 0.05 per common share, a 67% increase from the previous year [17] Non-IFRS Measures - Funds from Operations (FFO) for the three months ended September 30, 2025, were CAD 1,601,386, down from CAD 1,933,384 in 2024 [9] - Adjusted Cash Flows from Operations (ACFO) for the same period were CAD 1,966,346, compared to CAD 3,032,313 in 2024 [11]

Core Insights - ROHM Semiconductor has developed a new 100V power MOSFET, RS7P200BM, which features industry-leading Safe Operating Area (SOA) in a compact 5060-size package, suitable for hot-swap circuits in AI servers and industrial power supplies [1][3]. Industry Demand and Trends - The rapid adoption of AI technologies has heightened the need for stable operation and improved power efficiency in servers, particularly those utilizing generative AI and high-performance GPUs [2]. - The shift towards 48V power supplies is driven by the demand for better power conversion efficiency and energy conservation in data centers and AI servers [2]. Product Features and Specifications - The RS7P200BM achieves a low on-resistance (RDS(on)) of 4.0mΩ under specific conditions, while maintaining a wide SOA of 7.5A at a pulse width of 10ms and 25A at 1ms, which enhances power supply efficiency and reduces cooling loads [4]. - The new product is designed for high-density mounting, outperforming the previously released RY7P250BM in terms of size and efficiency [3][12]. Production and Availability - Mass production of the RS7P200BM commenced in September 2025, and it is available for online purchase through distributors like DigiKey and Mouser [5]. Future Developments - ROHM plans to continue expanding its product lineup for 48V power supplies, aiming to enhance energy efficiency and reliability in server systems and reduce power loss in data centers [6]. Application Examples - The RS7P200BM is suitable for various applications, including 48V system AI servers, industrial power supplies, battery-powered industrial equipment, and emergency power systems [7]. Brand Information - EcoMOS™ is ROHM's brand of silicon power MOSFETs designed for energy-efficient applications across various sectors, including home appliances and automotive systems [7].

Currently targeting strike extension of the gold-bearing veinsTORONTO, Nov. 25, 2025 (GLOBE NEWSWIRE) -- Q-Gold Resources Ltd. (TSXV: QGR; OTCQB: QGLDF) ("QGold" or the "Company") is pleased to announce commencement of its second diamond drilling campaign of 2025 at the Mine Centre Gold Project in northwestern Ontario. Rodren Drilling of Winnipeg, Manitoba has again been engaged as the drilling contractor. Critical Discoveries, a prominent geological consulting firm, also based in Winnipeg, Manitoba has bee ...

Core Viewpoint - Johnson Outdoors Inc. is set to release its financial results for the Fiscal 2025 fourth quarter on December 12, 2025, before market opening, followed by a conference call to discuss the results and provide company updates [1]. Company Overview - Johnson Outdoors Inc. is a leading global innovator in outdoor recreation equipment and technologies, aiming to inspire more people to enjoy the outdoors [3]. - The company designs, manufactures, and markets a diverse portfolio of consumer-preferred brands across four categories: Watercraft Recreation, Fishing, Diving, and Camping [3]. - Iconic brands under Johnson Outdoors include Old Town canoes and kayaks, Carlisle paddles, Minn Kota trolling motors, Cannon downriggers, Humminbird marine electronics, SCUBAPRO dive equipment, and Jetboil outdoor cooking systems [3]. Conference Call Details - A live listen-only webcast of the conference call will be available on Johnson Outdoors' homepage, with a replay accessible for 30 days in the Investor section of the website [2].

Core Points - Abitibi Metals Corp. has entered into an agreement with underwriters to raise approximately C$10 million through the sale of 12,300,000 charity flow-through common shares at C$0.57 each and 8,580,000 hard dollar common shares at C$0.35 each [1][3] - The offering is expected to close around December 16, 2025, pending necessary regulatory approvals [2] - Proceeds from the charity flow-through common shares will be used for the advancement of the B26 Polymetallic Deposit, while net proceeds from the common shares will be allocated for general corporate purposes [3] Company Overview - Abitibi Metals Corp. focuses on acquiring and exploring mineral properties in Quebec, emphasizing high-quality base and precious metal assets with significant growth potential [5]

Core Insights - BiomX Inc. is addressing FDA follow-up information requests to lift the clinical hold on the nebulizer device used in the Phase 2b trial of BX004 for cystic fibrosis patients [1][2][4] - An independent Data Monitoring Committee (DMC) has reviewed the safety of the BX004 Phase 2b trial and recommended that the study continue with an adjusted dosing regimen, with topline results now expected in Q2 2026 [3][4] Company Updates - The company is collaborating with a third-party manufacturer to provide the FDA with the necessary information to resolve outstanding questions regarding the nebulizer device [2][4] - BiomX has previously reported positive results from Part 1 and Part 2 of the Phase 1b/2a trials, demonstrating safety, tolerability, and improvement in pulmonary function in a specific patient subgroup [5] Product Information - BX004 is a multi-phage cocktail targeting Pseudomonas aeruginosa, a significant cause of morbidity in cystic fibrosis patients [5] - The company plans to enroll approximately 60 patients in a randomized, double-blind, placebo-controlled Phase 2b trial, pending the resolution of the FDA clinical hold [5]

Core Insights - Freddie Mac released its Monthly Volume Summary for October 2025, detailing its mortgage-related portfolios, securities issuance, risk management, delinquencies, debt activities, and other investments [1] Company Overview - Freddie Mac's mission is to enhance home accessibility for families nationwide, promoting liquidity, stability, and affordability in the housing market across various economic cycles [2] - Since its inception in 1970, Freddie Mac has assisted tens of millions of families in buying, renting, or maintaining their homes [2]

Core Viewpoint - Bright Minds Biosciences, Inc. is focused on developing highly selective 5-HT2 agonists for treating drug-resistant epilepsy, depression, and other CNS disorders, and is participating in key upcoming healthcare events [1][2]. Company Overview - Bright Minds Biosciences is a biotechnology company dedicated to creating innovative treatments for neurological and psychiatric disorders, with a pipeline that includes novel compounds targeting critical brain receptors [2]. - The company aims to address conditions with high unmet medical needs, including epilepsy and depression, by delivering breakthrough therapies that can significantly improve patients' lives [2]. Product Development - Bright Minds has developed a unique platform of highly selective serotonergic agonists that exhibit selectivity at various serotonergic receptors, resulting in a rich portfolio of new chemical entity (NCE) programs within neurology and psychiatry [3]. Upcoming Events - The company will participate in the Piper Sandler 37th Annual Healthcare Conference on December 3, 2025, at 11:30 am ET [1]. - Additionally, Bright Minds will be present at the 2025 American Epilepsy Society Annual Meeting during the Scientific Exhibit Session on December 7, 2025, from 2 pm to 5 pm ET [1].

Core Insights - BioAge Labs, Inc. is a clinical-stage biotechnology company focused on developing therapeutic products for metabolic diseases by targeting human aging biology [1][3] - The company will present at the Piper Sandler 37th Annual Healthcare Conference in New York from December 2-4, 2025 [1][2] - Key executives, including CEO Kristen Fortney and CFO Dov Goldstein, will participate in a fireside chat and one-on-one meetings during the conference [2] Company Overview - BioAge's lead product candidate, BGE-102, is an orally available small-molecule NLRP3 inhibitor aimed at treating obesity and cardiovascular risk factors [3] - A Phase 1 SAD/MAD trial for BGE-102 is currently underway, with initial SAD data expected by the end of the year [3] - The company is also developing long-acting injectable and oral small molecule APJ agonists for obesity, alongside additional preclinical programs targeting metabolic aging pathways [3]

Core Points - PhoneX Holdings, Inc. has appointed Vijay Ganapathy to the Board of Directors, effective November 20, 2025, succeeding Scott Tepfer who has resigned [1][2] - The company has adopted a Long-Term Cash Bonus Incentive Plan aimed at aligning employee incentives with long-term shareholder value creation [3][4] - The Plan allows for cash bonus payments contingent upon achieving measurable value-creation events, such as major corporate transactions and shareholder distributions [4][5] - Cash bonus awards under the Plan represent approximately 5% of Total Distributions at lower transaction thresholds, increasing to up to 15% for extraordinary outcomes [6] Company Overview - PhoneX Holdings, Inc. operates in the technology sector, focusing on the global wholesale trade of pre-owned mobile devices through its SaaS platform [7]